Mary K. Caffrey

Americans support more transparency in setting drug prices and letting Medicare negotiate with the pharmaceutical companies, according to the Kaiser Family Foundation poll.

The ITCA 650 device, which delivers tiny doses of exenatide, could be a game changer in solving the problem of medication adherence. An application for FDA approval is expected in the first half of 2016.

New York has a new law to protect consumers, and New Jersey and California are weighing similar legislation.

Winning bids reflect the trend of national insurers securing a large share of Medicaid managed care business as states seek savings and the Affordable Care Act allows for expansion.

The study may lead to more widespread use of the therapy, the lead author said. Coverage has been a challenge despite a declaration of obesity as a disease 2 years ago.

Diabetes is not just an epidemic in the United States; the nonprofit Diabetes UK warned that the disease is swamping the National Health Service with rising costs because not enough emphasis is placed on prevention.

Examples from many states show the tension between the desire the hold down costs and the need to address the specialized medical issues of patients with life-threatening illnesses, which can be very expensive to treat.

A report from the Government Accountability Office has found that a program for hospitals serving poor and uninsured patients has created perverse incentives to prescribe more drugs and more expensive drugs, particularly in the area of cancer care.

The recent mergers between healthcare payers continue the trend of consolidation that has swept the healthcare industry since passage of the ACA.

More signed up under Medicaid expansion than expected, but use of technology and management tools have kept costs $2 billion below estimates.

The study published in Diabetes Care showed that a relatively simple intervention reduced gestational diabetes 39% for women at risk.

More employers are requiring prior authorization and the use of select specialty pharmacies for high-cost drugs.

After months of waiting, reimbursement for the Prolaris test will begin effective October 15, 2015.

Evidence-Based Oncology spoke with Mark Capone about the challenges and opportunities in molecular diagnostics, and what's ahead at Myriad Genetics.

The Pregnancy Discrimination Act of 1978 prevents questions about status from being asked, and does not require a woman to disclose her pregnancy in an interview.

A Gallup survey found that only Texas still has 20% of adults who lack insurance. In 2013, 14 states had uninsured rates above 20%.

The move comes after Sanofi and Regeneron spent $67.5 million to move ahead of the main competitor in the FDA approval process.

A recent Kaiser Family Foundation survey found 70% of Americans prefer that Medicare's benefit structure remain intact.

Critics of Coke's financial support said its was not transparent until scholars forced its revelation, and that it's a gambit to steer attention away from the role of soda in the nation's epidemic of diabetes and obesity.

The CDC report underscores last year's recommendation from the American Academy of Pediatrics. American teenagers are not getting enough sleep because in most places the school days start too early.

Donald Trump's call to "get rid of the artificial lines" references a discussion about the optional federal insurance charter, which has been going on in business circles for more than 15 years.

Patients in practices where certified diabetes educators were embedded in practices were more likely to have medication adjusted quickly, with better health outcomes.

Natasha Greene, PhD, FNP, BC, found that educating a family member alongside the person with type 2 diabetes mellitus produced better health outcomes than traditional education.

The study presented at the ADA Scientific Sessions found that raising out-of-pocket costs for diabetics with Medicare could reduce adherence and ultimately raise healthcare spending.

Younger patients and those who have been diagnosed less than 5 years are less likely to follow guidelines for regular eye exams, despite the risk of blindness.

Defining what is "medically necessary" is a judgment call, and patients may lack access to the criteria insurers use to make coverage decisions.

The shift in care for those with diabetes is about new payment models and a change in mindset, said the speakers, including Robert A. Gabbay, MD, PhD, of Joslin Diabetes Center.

A matchstick-like device provides continuous delivery of exenatide, producing dramatic reductions in A1C levels.

The sessions offered a backgroup to announced new partnerships and reveal new technology.

The study evaluated the 3 new anti-VEGF agents for treatment of a condition that frequently occurs in patients who suffer from diabetes mellitus.